Orrin Hatch: “Is it possible for FDA to trace adverse events and identify the source without a unique identifier in the name?”

for more than four decades, I have had the distinct privilege of serving in the U.S. Senate, what some have called the world's greatest deliberative body. Speaking on the Senate floor, debating legislation in committee, corralling the…

I appreciate the majority leader's remarks in a wide variety of ways. What a great leader he is. We all should pay very strict attention to the way he handles himself and his seriousness about our U.S. Senate. Last night, Senate Democrats…

I wish to enter a few remarks into the Record regarding section 103(a) of the Music Modernization Act, which the Senate recently passed. By striking current sections 114(f)(1) and (2) of title 17 and substituting a new section 114(f)(1)…

Having a confirmed Commissioner and sustained leadership will benefit the Social Security Administration.